while waiting for FDA approval of denosumab(RANKL inhibitor vs bone mets,osteoporosis

[Lani]

...it turns out that an already approved drug imatinib (Gleevec) approved for leukemia and GIST has a similar effect, at least preclinically in mice--

http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&Year=2009&Month=01&id=15938